Mylan Exudes Confidence About Plan For Biogenerics
This article was originally published in The Pink Sheet Daily
Executive Summary
At a Feb. 21 investor day, Mylan discussed its long-term goals for launching several biosimilars, as well some hard-to-reproduce generic offerings.